Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H. (Q43448245)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 April 2014

Language	Label	Description	Also known as
English	Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.	scientific article published on 3 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

based on heuristic

inferred from title

Yoshiki Akatsuka

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Y Inaguma

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Y Akahori

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Y Murayama

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

K Shiraishi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

S Tsuzuki-Iba

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

A Endoh

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

J Tsujikawa

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

A Demachi-Okamura

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

K Hiramatsu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

H Saji

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Y Yamamoto

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

N Yamamoto

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Y Nishimura

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

T Takahashi

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

K Kuzushima

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

N Emi

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

3 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

575-584

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

https://scigraph.springernature.com/pub.10.1038/gt.2014.30

0 references

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Mixed T cell receptor dimers harbor potentially harmful neoreactivity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Chimeric antigen receptor-engineered T cells for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Treating cancer with genetically engineered T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Rational development of high-affinity T-cell receptor-like antibodies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Prediction of proteasome cleavage motifs by neural networks

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

The Serial Engagement Model 17 Years After: From TCR Triggering to Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Molecular interactions mediating T cell antigen recognition

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Isolation of human monoclonal antibodies that neutralize human rotavirus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Recombinant antibodies with MHC‐restricted, peptide‐specific, T‐cell receptor‐like specificity: new tools to study antigen presentation and TCR–peptide–MHC interactions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Expression vectors for the introduction of highly diverged sequences into the six complementarity-determining regions of an antibody

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

21 January 2018

Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2014.30

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GT.2014.30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Dimensions Publication ID

0 references

release_srvgzqltenfnpjgqvkyqygfofm

1 reference

https://api.fatcat.wiki/v0/release/srvgzqltenfnpjgqvkyqygfofm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24694533%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43448245&oldid=1843032602"